Literature DB >> 2822243

Depressed natural cytotoxicity but normal natural killer cytotoxic factor (NKCF) production by mononuclear cells derived from patients with hepatocellular carcinoma.

R H Brookes1, M C Kew, A R Rabson.   

Abstract

This study investigated the relation between the production of natural killer cytotoxic factors (NKCF) and the phenomenon of natural killing (NK) activity against target K562 cells. Two different models of defective NK cell activity were employed. In the first instance, cytotoxic activity of mononuclear cells (MN) derived from patients with hepatocellular carcinoma was compared to the ability of these cells to produce NKCF. Although direct cytotoxicity was considerably impaired in these patients, the ability of their MN to produce NKCF when stimulated with K562 cells was found to be normal. In the second model, MN treated with the lysosomotropic drug monensin showed considerably reduced direct cytotoxic activity, although they were capable of producing normal amounts of NKCF when activated by K562 cells. These results therefore indicate that there is no correlation between NK activity and corresponding NKCF release, and suggest that NKCF production and activity is independent of direct NK cytotoxic activity.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2822243     DOI: 10.1007/BF00199956

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  22 in total

1.  Purification and characterization of a cytolytic pore-forming protein from granules of cloned lymphocytes with natural killer activity.

Authors:  J D Young; H Hengartner; E R Podack; Z A Cohn
Journal:  Cell       Date:  1986-03-28       Impact factor: 41.582

2.  Studies on the lethal hit stage of natural killer cell-mediated cytotoxicity. I. Both phorbol ester and ionophore are required for release of natural killer cytotoxic factors (NKCF), suggesting a role for protein kinase C activity.

Authors:  S S Graves; J Bramhall; B Bonavida
Journal:  J Immunol       Date:  1986-09-15       Impact factor: 5.422

3.  Role of natural killer cytotoxic factors in the mechanism of target-cell killing by natural killer cells.

Authors:  B Bonavida; S C Wright
Journal:  J Clin Immunol       Date:  1986-01       Impact factor: 8.317

4.  Differential effects of various pharmacological agents on the cytolytic reaction mechanism of the human natural killer lymphocyte: further resolution of programming for lysis and KCIL into discrete stages.

Authors:  J C Hiserodt; L J Britvan; S R Targan
Journal:  J Immunol       Date:  1982-11       Impact factor: 5.422

5.  Assembly of two types of tubules with putative cytolytic function by cloned natural killer cells.

Authors:  E R Podack; G Dennert
Journal:  Nature       Date:  1983 Mar 31-Apr 6       Impact factor: 49.962

6.  Selective lysis of NK-sensitive target cells by a soluble mediator released from murine spleen cells and human peripheral blood lymphocytes.

Authors:  S C Wright; B Bonavida
Journal:  J Immunol       Date:  1981-04       Impact factor: 5.422

7.  Natural killer-sensitive targets stimulate production of TNF-alpha but not TNF-beta (lymphotoxin) by highly purified human peripheral blood large granular lymphocytes.

Authors:  P M Peters; J R Ortaldo; M R Shalaby; L P Svedersky; G E Nedwin; T S Bringman; P E Hass; B B Aggarwal; R B Herberman; D V Goeddel
Journal:  J Immunol       Date:  1986-10-15       Impact factor: 5.422

8.  Capacity of human large granular lymphocytes (LGL) to produce multiple lymphokines: interleukin 2, interferon, and colony stimulating factor.

Authors:  T Kasahara; J Y Djeu; S F Dougherty; J J Oppenheim
Journal:  J Immunol       Date:  1983-11       Impact factor: 5.422

9.  Comparative studies of intracellular transport of secretory proteins.

Authors:  A Tartakoff; P Vassalli; M Détraz
Journal:  J Cell Biol       Date:  1978-12       Impact factor: 10.539

10.  Monensin and FCCP inhibit the intracellular transport of alphavirus membrane glycoproteins.

Authors:  L Kääriäinen; K Hashimoto; J Saraste; I Virtanen; K Penttinen
Journal:  J Cell Biol       Date:  1980-12       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.